Skip to content
Clinical Trials – home

Centre Hospitalier de Grasse

Research site

France Chemin de Clavary, 06130 Grasse, France

  • 2 trials recruiting
  • Hormone receptor positive HER2 negative breast cancer · Medical device site joint infection · Non-small cell lung cancer stage IV
  • Adult patients

About Specializations

Centre Hospitalier de Grasse in Grasse, France specialises in clinical trials of conditions such as Hormone receptor positive HER2 negative breast cancer, Medical device site joint infection, Non-small cell lung cancer stage IV, and other specialisations. This site conducts important research.

Main research areas of the site

Infectious Diseases and Microbiota

The medical center is at the forefront of research in infectious diseases, with a particular focus on ostearticular infections associated with prosthetic devices. This area of study is crucial for understanding the complex interactions between antibiotic therapies and the digestive microbiota.

  • Osteoarticular Infections
  • Antibiotic Impact on Microbiota
  • Prosthetic Device Infections

By exploring the biodiversity of the gut microbiota in patients undergoing different antibiotic treatments, the center contributes significantly to the development of more effective therapeutic strategies and enhances our understanding of microbial ecology in the context of infection.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Chemin de Clavary06130 GrasseFrance
Recruiting now
2 trials
Conditions studied
3

More sites in GrasseFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on the Impact of Cefepime, Piperacillin-Tazobactam, and Ceftobiprole on Gut Health in Patients with Bone and Joint Infections on Implants

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cefepime
  • Sponsor:Centre Hospitalier Universitaire De Nice

Study on Maintenance Treatment with Pembrolizumab and Pemetrexed for Stage IV Non-Small Cell Lung Cancer Patients After Initial Chemotherapy and Immunotherapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Study on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.